Watters C, Brar S, Pepper T. Oral mucosa cancer. 2020.

Tranby EP, Heaton LJ, Tomar SL, Kelly AL, Fager GL, Backley M, Frantsve-Hawley J. Oral cancer prevalence, mortality, and costs in medicaid and commercial insurance claims data. Cancer Epidemiol Biomarkers Prev. 2022;31(9):1849–57.

Article  PubMed  PubMed Central  Google Scholar 

Tshering Vogel DW, Zbaeren P, Thoeny HC. Cancer of the oral cavity and oropharynx. Cancer Imaging. 2010;10(1):62–72.

Article  PubMed  Google Scholar 

Ram H, Sarkar J, Kumar H, Konwar R, Bhatt ML, Mohammad S. Oral cancer: risk factors and molecular pathogenesis. J Maxillofac Oral Surg. 2011;10(2):132–7.

Article  PubMed  PubMed Central  Google Scholar 

Hernandez BY, Zhu X, Goodman MT, Gatewood R, Mendiola P, Quinata K, Paulino YC. Betel nut chewing, oral premalignant lesions, and the oral microbiome. PLoS ONE. 2017;12(2): e0172196.

Article  PubMed  PubMed Central  Google Scholar 

Manoharan S, Karthikeyan S, Essa MM, Manimaran A, Selvasundram R. An overview of oral carcinogenesis. Int J Nutr, Pharmacol Neurol Dis. 2016;6(2):51–62.

Article  CAS  Google Scholar 

Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.

Article  PubMed  PubMed Central  Google Scholar 

Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, et al. The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer. 2019;7(1):184.

Article  PubMed  PubMed Central  Google Scholar 

Haring CT, Kana LA, Dermody SM, Brummel C, McHugh JB, Casper KA, Chinn SB, Malloy KM, Mierzwa M, Prince ME. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols. Cancer. 2023;129(18):2817–27.

Article  PubMed  Google Scholar 

Badwelan M, Muaddi H, Ahmed A, Lee KT, Tran SD. Oral squamous cell carcinoma and concomitant primary tumors, what do we know? a review of the literature. Curr Oncol. 2023;30(4):3721–34.

Article  PubMed  PubMed Central  Google Scholar 

Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010;46(6):414–7.

Article  PubMed  Google Scholar 

Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol. 1999;35(2):173–9.

Article  CAS  PubMed  Google Scholar 

Cho U, Sung YE, Kim MS, Lee YS. Prognostic Role of systemic inflammatory markers in patients undergoing surgical resection for oral squamous cell carcinoma. Biomedicines. 2022;10(6):1268.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almangush A, Leivo I, Mäkitie AA. Biomarkers for immunotherapy of oral squamous cell carcinoma: current status and challenges. Front Oncol. 2021;11: 616629.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olmos M, Glajzer J, Büntemeyer T-O, Frohwitter G, Ries J, Eckstein M, Hecht M, Lutz R, Kesting MR, Weber M. Neoadjuvant immunotherapy of oral squamous cell carcinoma: case report and assessment of histological response. Front Oncol. 2021;11: 720951.

Article  PubMed  PubMed Central  Google Scholar 

Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29(1):83.

Article  PubMed  PubMed Central  Google Scholar 

Wright K, Ly T, Kriet M, Czirok A, Thomas SM. Cancer-associated fibroblasts: master tumor microenvironment modifiers. Cancers (Basel). 2023;15(6):1899.

Article  CAS  PubMed  Google Scholar 

Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, Du J, Liu L, Li Y, Bai Y. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14(9):587.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Philips R, Han C, Swendseid B, Curry J, Argiris A, Luginbuhl A, Johnson J. Preoperative immunotherapy in the multidisciplinary management of oral cavity cancer. Front Oncol. 2021;11: 682075.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eulberg D, Frömming A, Lapid K, Mangasarian A, Barak A. The prospect of tumor microenvironment-modulating therapeutical strategies. Front Oncol. 2022;12:1070243.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Yang M, Zhang D, Chen M, Zhu D. Clinical cancer immunotherapy: Current progress and prospects. Front Immunol. 2022;13:961805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, Ladwa R, O’Byrne K, Kulasinghe A. Immune checkpoint inhibitors in cancer therapy. Curr Oncol. 2022;29(5):3044–60.

Article  PubMed  PubMed Central  Google Scholar 

Brahmer JR, Abu-Sbeih H, Ascierto PA, Brufsky J, Cappelli LC, Cortazar FB, Gerber DE, Hamad L, Hansen E, Johnson DB, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer. 2021;9(6):e002435.

Article  PubMed  PubMed Central  Google Scholar 

Kluger H, Barrett JC, Gainor JF, Hamid O, Hurwitz M, LaVallee T, Moss RA, Zappasodi R, Sullivan RJ, Tawbi H, et al. Society for immunotherapy of cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. J Immunother Cancer. 2023;11(3):e005921.

Article  PubMed  PubMed Central  Google Scholar 

Kciuk M, Yahya EB, Mohamed Ibrahim Mohamed M, Rashid S, Iqbal MO, Kontek R, Abdulsamad MA, Allaq AA. Recent advances in molecular mechanisms of cancer immunotherapy. Cancers (Basel). 2023;15(10):2721.

Article  CAS  PubMed  Google Scholar 

Disis ML. Mechanism of action of immunotherapy. Semin Oncol. 2014;41:S3–13.

Article  CAS  PubMed  Google Scholar 

Wang Z, Sun W, Hua R, Wang Y, Li Y, Zhang H. Promising dawn in tumor microenvironment therapy: engineering oral bacteria. Int J Oral Sci. 2024;16(1):24.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Pandey V, Bhardwaj V, Zhu T, Lobie PE. Autocrine/paracrine growth hormone in cancer progression. Endocr Relat Cancer. 2024. https://doi.org/10.1530/ERC-23-0120.

Article  PubMed  PubMed Central  Google Scholar 

Sarkar M, Nguyen T, Gundre E, Ogunlusi O, El-Sobky M, Giri B, Sarkar TR. Cancer-associated fibroblasts: the chief architect in the tumor microenvironment. Front Cell Develop Biol. 2023;11:1089068.

Article  Google Scholar 

Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities. Cancers (Basel). 2021;13(9):2053.

Article  CAS  PubMed  Google Scholar 

Lu C, Liu Y, Ali NM, Zhang B, Cui X. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. Front Immunol. 2022;13:1039260.

Article  CAS  PubMed  Google Scholar